Main menu

NEW YORK (GenomeWeb News) – Shares in Nanogen were up 6.7 percent, or $.12, at $1.92 in early-afternoon trading after the company said it won six US patents covering inventions related to diabetes and Alzheimer’s disease and biomarkers.